COMPETITIVE-INHIBITION OF COUMARIN 7-HYDROXYLATION BY PILOCARPINE AND ITS INTERACTION WITH MOUSE CYP 2A5 AND HUMAN CYP 2A6

被引:28
作者
KINONEN, T
PASANEN, M
GYNTHER, J
POSO, J
JARVINEN, T
ALHAVA, E
JUVONEN, RO
机构
[1] UNIV KUOPIO,DEPT PHARMACOL & TOXICOL,SF-70211 KUOPIO,FINLAND
[2] UNIV KUOPIO,DEPT SURG,SF-70211 KUOPIO,FINLAND
[3] UNIV KUOPIO,DEPT PHARMACEUT CHEM,SF-70211 KUOPIO,FINLAND
关键词
CYP; 2A5; PILOCARPINE; COUMARIN; ENZYME INHIBITION;
D O I
10.1111/j.1476-5381.1995.tb17217.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 We have shown earlier that pilocarpine strongly inhibits mouse and human liver coumarin 7-hydroxylase activity of CYP 2A and pentoxyresorufin O-deethylase activity of CYP 2B in vitro. Since pilocarpine, like coumarin, contains a lactone structure we have studied in more detail its inhibitory potency on mouse and human liver coumarin 7-hydroxylation. 2 Pilocarpine was a competitive inhibitor of coumarin 7-hydroxlase in vitro both in mouse and human liver microsomes although it was not a substrate for CYP 2A5. K-i values were similar, 0.52 +/- 0.22 mu M in mice and 1.21 +/- 0.51 mu M in human liver microsomes. 3 Pilocarpine induced a type II difference spectrum in mouse, human and recombinant CYP 2A5 yeast cell microsomes, with K-a values of 3.7 +/- 1.6, 1.6 +/- 1.1 and 1.5 +/- 0.1 mu M, respectively. 4 Increase in pH of the incubation medium from pH 6 to 7.5 increased the potency of inhibition of coumarin 7-hydroxylation by pilocarpine. 5 Superimposition of pilocarpine and coumarin in such a way that their carbonyls, ring oxygens and the H-7' of coumarin and N-3 of pilocarpine overlap yielded a common molecular volume of 82%. 6 The results indicate that pilocarpine is a competitive inhibitor and has a high affinity for mouse CYP 2A5 and human CYP 2A6. In addition the immunotype nitrogen of pilocarpine is coordinated towards the haem iron in these P450s.
引用
收藏
页码:2625 / 2630
页数:6
相关论文
共 25 条
[1]   SIMPLE AND SENSITIVE ASSAY OF 7-ETHOXYCOUMARIN DEETHYLATION [J].
AITIO, A .
ANALYTICAL BIOCHEMISTRY, 1978, 85 (02) :488-491
[2]   VALIDATION OF THE GENERAL-PURPOSE TRIPOS 5.2 FORCE-FIELD [J].
CLARK, M ;
CRAMER, RD ;
VANOPDENBOSCH, N .
JOURNAL OF COMPUTATIONAL CHEMISTRY, 1989, 10 (08) :982-1012
[3]   CRITICAL-REVIEW OF THE TOXICOLOGY OF COUMARIN WITH SPECIAL REFERENCE TO INTERSPECIES DIFFERENCES IN METABOLISM AND HEPATOTOXIC RESPONSE AND THEIR SIGNIFICANCE TO MAN [J].
COHEN, AJ .
FOOD AND COSMETICS TOXICOLOGY, 1979, 17 (03) :277-289
[4]   THE PHARMACOLOGY, METABOLISM, ANALYSIS, AND APPLICATIONS OF COUMARIN AND COUMARIN-RELATED COMPOUNDS [J].
EGAN, D ;
OKENNEDY, R ;
MORAN, E ;
COX, D ;
PROSSER, E ;
THORNES, RD .
DRUG METABOLISM REVIEWS, 1990, 22 (05) :503-529
[5]  
GIBSON GG, 1989, XENOBIOTICA, V14, P27
[6]   CYTOCHROME P4502A-MEDIATED COUMARIN 7-HYDROXYLATION AND TESTOSTERONE HYDROXYLATION IN MOUSE AND RAT LUNG [J].
HONKAKOSKI, P ;
MAENPAA, J ;
LEIKOLA, J ;
PASANEN, M ;
JUVONEN, R ;
LANG, MA ;
PELKONEN, O ;
RAUNIO, H .
PHARMACOLOGY & TOXICOLOGY, 1993, 72 (02) :107-112
[7]   DETERMINATION OF PHYSICOCHEMICAL PROPERTIES, STABILITY IN AQUEOUS-SOLUTIONS AND SERUM HYDROLYSIS OF PILOCARPIC ACID DIESTERS [J].
JARVINEN, T ;
SUHONEN, P ;
NAUMANEN, H ;
URTTI, A ;
PEURA, P .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1991, 9 (09) :737-745
[8]  
JEFCOATE CR, 1978, METHOD ENZYMOL, V11, P258
[9]   PURIFICATION AND CHARACTERIZATION OF A LIVER MICROSOMAL CYTOCHROME-P-450 ISOENZYME WITH A HIGH-AFFINITY AND METABOLIC CAPACITY FOR COUMARIN FROM PYRAZOLE-TREATED D2 MICE [J].
JUVONEN, RO ;
SHKUMATOV, VM ;
LANG, MA .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1988, 171 (1-2) :205-211
[10]  
JUVONEN RO, 1991, J BIOL CHEM, V266, P16431